Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 13 results:
Author Title [ Type(Desc)] Year
Filters: Author is Vasilakis, C.  [Clear All Filters]
Journal Article
C. R. Meier, Jick, S. S., Derby, L. E., Vasilakis, C., and Jick, H., Acute respiratory-tract infections and risk of first-time acute myocardial infarction, Lancet, vol. 351, pp. 1467-71, 1998.
C. R. Meier, Derby, L. E., Jick, S. S., Vasilakis, C., and Jick, H., Antibiotics and risk of subsequent first-time acute myocardial infarction, Jama, vol. 281, pp. 427-31, 1999.
H. Jick, Vasilakis, C., and Derby, L. E., Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension, Epidemiology, vol. 8, pp. 446-8, 1997.
M. W. Myers, Vasilakis, C., Kaufman, M. R., and Jick, H., Antihypertensive drugs and the risk of idiopathic aplastic anaemia, Br J Clin Pharmacol, vol. 49, pp. 604-8, 2000.
H. Jick, Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., and Derby, L. E., A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation, N Engl J Med, vol. 339, pp. 719-24, 1998.
S. S. Jick, Vasilakis, C., and Jick, H., Pregnancies and terminations after 1995 warning about third-generation oral contraceptives, Lancet, vol. 351, pp. 1404-5, 1998.
H. Jick, Jick, S. S., Gurewich, V., Myers, M. W., and Vasilakis, C., Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components, Lancet, vol. 346, pp. 1589-93, 1995.
C. Vasilakis, Jick, H., and M. Melero-Montes, delMar, Risk of idiopathic venous thromboembolism in users of progestagens alone, Lancet, vol. 354, pp. 1610-1, 1999.
H. Jick, Derby, L. E., Gurewich, V., and Vasilakis, C., The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension, Pharmacotherapy, vol. 16, pp. 321-6, 1996.
H. Jick, Derby, L. E., Vasilakis, C., and Fife, D., The risk of seizures associated with tramadol, Pharmacotherapy, vol. 18, pp. 607-11, 1998.
C. Gasse, Derby, L. E., Vasilakis, C., and Jick, H., Risk of suicide among users of calcium channel blockers: population based, nested case-control study, Bmj, vol. 320, p. 1251, 2000.
C. Vasilakis, Jick, S. S., and Jick, H., The risk of venous thromboembolism in users of postcoital contraceptive pills, Contraception, vol. 59, pp. 79-83, 1999.
S. S. Jick, Vasilakis, C., Martinez, C., and Jick, H., A study of the relation of exposure to quinolones and suicidal behaviour, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
[Page last reviewed 6 April 2021]